These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16000684)

  • 1. Delirium resolving upon switching from risperidone to quetiapine: implication of CYP2D6 genotype.
    Kato D; Kawanishi C; Kishida I; Furuno T; Matsumura T; Hasegawa H; Hirayasu Y
    Psychosomatics; 2005; 46(4):374-5. PubMed ID: 16000684
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quetiapine treatment of risperidone-related tardive dyskinesia. A case report].
    Alcantara Lapaz AG; García Fernández L; Martínez MJ
    Actas Esp Psiquiatr; 2003; 31(5):306. PubMed ID: 14557956
    [No Abstract]   [Full Text] [Related]  

  • 3. Risperidone-induced delirium.
    Tavcar R; Dernovsek MZ
    Can J Psychiatry; 1998 Mar; 43(2):194. PubMed ID: 9533974
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone.
    Köhnke MD; Griese EU; Stösser D; Gaertner I; Barth G
    Pharmacopsychiatry; 2002 May; 35(3):116-8. PubMed ID: 12107857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation.
    Ochi S; Kawasoe K; Abe M; Fukuhara R; Sonobe K; Kawabe K; Ueno S
    Gen Hosp Psychiatry; 2011; 33(6):640.e1-2. PubMed ID: 21749835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine in the treatment of postoperative delirium. A report of three cases.
    Khouzam HR
    Compr Ther; 2008; 34(3-4):207-17. PubMed ID: 19137765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label study of quetiapine for delirium.
    Maneeton B; Maneeton N; Srisurapanont M
    J Med Assoc Thai; 2007 Oct; 90(10):2158-63. PubMed ID: 18041437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
    Byerly MJ; Nakonezny PA; Rush AJ
    Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia.
    Yagihashi T; Mizuno M; Chino B; Sato Y; Sakuma K; Takebayashi T; Takao T; Kosaki K
    Hum Psychopharmacol; 2009 Jun; 24(4):301-8. PubMed ID: 19387994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine.
    Lam MH; Fong SY; Wing YK
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):333. PubMed ID: 17472606
    [No Abstract]   [Full Text] [Related]  

  • 11. Risperidone and tardive dyskinesia in organic psychosis.
    Fischer P; Tauscher J; Küfferle B
    Pharmacopsychiatry; 1998 Mar; 31(2):70-1. PubMed ID: 9562212
    [No Abstract]   [Full Text] [Related]  

  • 12. Quetiapine as treatment for delirium during weaning from ventilation: a case report.
    Seemüller F; Volkmer E; Vogel T; Hummel T; Krauseneck T; Riedel M; Padberg F
    J Clin Psychopharmacol; 2007 Oct; 27(5):526-8. PubMed ID: 17873696
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone-induced thrombocytopenia: a case report.
    Semba J; Okui S
    Gen Hosp Psychiatry; 2009; 31(1):97-8. PubMed ID: 19134517
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients.
    Miyaji S; Yamamoto K; Hoshino S; Yamamoto H; Sakai Y; Miyaoka H
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):275-82. PubMed ID: 17472596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine associated with acute mental status changes.
    Sim FH; Brunet DG; Conacher GN
    Can J Psychiatry; 2000 Apr; 45(3):299. PubMed ID: 10779894
    [No Abstract]   [Full Text] [Related]  

  • 17. High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity.
    Coffey GL; Botts SR; de Leon J
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):770-4. PubMed ID: 15927338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable sustained-release risperidone: recurrence of delirium and treatment failure.
    Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131515
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyp2d6*3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side-effects in patients receiving antipsychotic therapy.
    Crescenti A; Mas S; Gassó P; Parellada E; Bernardo M; Lafuente A
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):807-11. PubMed ID: 18346175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.